TKPHF - Takeda Pharmaceutical Company Limited (TAK) CEO Christophe Weber on Q4 2022 Results - Earnings Call Transcript
Takeda Pharmaceutical Company Limited (TAK) Q4 2022 Earnings Conference Call May 11, 2022 06:00 AM ET Company Participants Ayako Iwamuro - IR Christophe Weber - CEO Andy Plump - R&D President Constantine Saroukos - CFO Giles Platford - President of the PDT Business Unit Julie Kim - President, U.S. Business Unit & U.S. Country Head Ramona Sequeira - President, Global Portfolio Division Masato Iwasaki - Representative Director Conference Call Participants Shinichiro Muraoka - Morgan Stanley Stephen Barker - Jefferies Seiji Wakao - JPMorgan Chase & Co Stacy Ku - Cowen and Company Fumiyoshi Sakai - Crédit Suisse Hidemaru Yamaguchi - Citigroup Presentation Ayako Iwamuro Thank you very much for your participation in Fiscal Year 2021 Earnings webinar of Takeda Pharmaceuticals. I am Ayako Iwamuro, IR of Takeda Pharmaceuticals. [Operator Instructions] Before starting, I'd like to remind everyone that we'll be discussing forward-looking statements within the meaning of the Private Securities
For further details see:
Takeda Pharmaceutical Company Limited (TAK) CEO Christophe Weber on Q4 2022 Results - Earnings Call Transcript